Table 2.
Total cholesterol | <200 mg/dL | ≥200 mg/dL | Continuous§ |
---|---|---|---|
Unadjusted | Ref. | 1.13 (0.90–1.43), p=0.294 | 1.02 (0.98, 1.05), p=0.365 |
Adjusted* | Ref. | 1.09 (0.85–1.39), p=0.493 | 1.02 (0.98, 1.05), p=0.407 |
LDL | <130 mg/dL | ≥130 mg/dL | Continuous§ |
Unadjusted | Ref. | 1.03 (0.81–1.31), p=0.824 | 1.00 (0.96, 1.03), p=0.832 |
Adjusted* | Ref. | 1.01 (0.78–1.30), p=0.944 | 0.99 (0.95, 1.04), p=0.768 |
HDL | ≥40 mg/dL | <40 mg/dL | Continuous§ |
Unadjusted | Ref. | 1.12 (0.89–1.41), p=0.339 | 0.99 (0.92, 1.07), p=0.854 |
Adjusted* | Ref. | 1.11 (0.87–1.41), p=0.402 | 0.97 (0.89, 1.04), p=0.378 |
Triglycerides | <150 mg/dL | ≥150 mg/dL | Continuous§ |
Unadjusted | Ref. | 1.15 (0.91–1.46), p=0.250 | 1.02 (1.01,1.03), p=0.006 |
Adjusted* | Ref. | 1.35 (1.05–1.74), p=0.020 | 1.02 (1.01, 1.04), p<0.001 |
Cells display hazard ratio (95% confidence interval), p-value
HDL=high density lipoprotein; LDL=low density lipoprotein
Hazard ratios are for every 10 mg/dL increase
Hazard ratios are adjusted for age, race, pre-operative PSA, year of surgery, BMI, surgical center, statin use, pathological Gleason score, prostate weight, positive surgical margins, extracapsular extension, and seminal vesicle invasion